➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Boehringer Ingelheim
AstraZeneca
Moodys
Johnson and Johnson

Last Updated: August 6, 2020

DrugPatentWatch Database Preview

CALCIJEX Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Calcijex patents expire, and when can generic versions of Calcijex launch?

Calcijex is a drug marketed by Abbvie and is included in one NDA. There are three patents protecting this drug.

The generic ingredient in CALCIJEX is calcitriol. There are ten drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the calcitriol profile page.

US ANDA Litigation and Generic Entry Outlook for Calcijex

A generic version of CALCIJEX was approved as calcitriol by TEVA on October 12th, 2001.

  Start Trial

Summary for CALCIJEX
Drug patent expirations by year for CALCIJEX
Recent Clinical Trials for CALCIJEX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
AbbottPhase 4

See all CALCIJEX clinical trials

Paragraph IV (Patent) Challenges for CALCIJEX
Tradename Dosage Ingredient NDA Submissiondate
CALCIJEX INJECTABLE;INJECTION calcitriol 018874

US Patents and Regulatory Information for CALCIJEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 DISCN Yes No   Start Trial   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 DISCN Yes No   Start Trial   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 DISCN Yes No   Start Trial   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986 DISCN Yes No   Start Trial   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 DISCN Yes No   Start Trial   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CALCIJEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-001 Sep 25, 1986   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986   Start Trial   Start Trial
Abbvie CALCIJEX calcitriol INJECTABLE;INJECTION 018874-002 Sep 25, 1986   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
AstraZeneca
McKesson
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.